Erik P. Castle, MD, presented “Recent Advances for Renal Cell Carcinoma: A 2018 Review” during the 27th Annual Perspectives in Urology: Point Counterpoint on November 9, 2018 in Scottsdale, Arizona.
How to cite: Castle, Erik P. “Recent Advances for Renal Cell Carcinoma: A 2018 Review” November 9, 2018. Accessed Dec 2020. https://grandroundsinurology.com/recent-advances-for-renal-cell-carcinoma-a-2018-review/
Recent Advances for Renal Cell Carcinoma: A 2018 Review – Summary:
Erik P. Castle, MD, highlights recent advances in surgery, individualized medicines, and immunotherapies for patients with renal cell carcinoma (RCC). He reviews updates in genetic sequencing and CAR-T cell therapy, as well as developing role of cancer-associated macrophage-like cells (CAMLs), in these patients.
About Perspectives in Urology: Point Counterpoint
Perspectives in Urology: Point Counterpoint (PCP) is an annual CME-accredited conference devoted to discussing and debating the latest topics in men’s health, general urology, and genitourinary cancers. The conference’s format includes more than didactic lectures. It also includes debates, point-counterpoint discussion panels, and unique case-based presentations. Dr. Castle presented this lecture during the 27th PCP in 2018. Please visit this page in order to register for future PCP meetings.